Physician
Child Adolescent Health Associates of the New River Valley PC
Child Adolescent Health Associates of the New River Valley PC was paid $5.46M by Medicaid between Jan 2018 and Dec 2024, across 51 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoCHILD ADOLESCENT HEALTH ASSOCIATES OF THE NEW RIVER VALLEY PC
RADFORD, VA 24141
RADFORD, VA 24141
33aNPI1144239039assigned 08/07/2006
33bProvider typePediatrics Physician
28Total paid$5.46M
24GClaims140,333
24DCodes billed51
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Virginia
Rank by total paid#25 of 817
Median peer was paid$29K
This provider vs. median187×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,273 | $123K | |
| 2019 | 21,665 | $807K | |
| 2020 | 19,114 | $667K | |
| 2021 | 23,581 | $871K | |
| 2022 | 26,407 | $1.08M | |
| 2023 | 27,072 | $1.05M | |
| 2024incomplete | 19,221 | $868K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 33,902 | 31,339 | $2.06M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 14,611 | 13,440 | $1.25M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.5% | 6,570 | 6,413 | $521K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.7% | 5,601 | 5,311 | $419K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.3% | 2,299 | 2,261 | $180K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.2% | 3,501 | 3,341 | $118K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.8% | 7,373 | 6,910 | $96K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.6% | 1,437 | 1,354 | $90K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.6% | 2,909 | 2,760 | $85K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 5,653 | 2,996 | $83K |
| 90670 | 1.3% | 3,189 | 3,112 | $68K | |
| 90686 | 1.2% | 5,570 | 5,436 | $64K |
39 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.0% | 649 | $56K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 14,770 | $53K |
| 92551 | <1% | 4,627 | $46K | |
| 90677 | <1% | 586 | $32K | |
| 90723 | <1% | 2,172 | $31K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 209 | $26K |
| 90647 | <1% | 2,201 | $26K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,087 | $22K |
| 99188 | <1% | 837 | $18K | |
| 90461 | <1% | 7,894 | $17K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,895 | $17K |
| 96127 | <1% | 2,189 | $11K | |
| 90681 | <1% | 620 | $10K | |
| 90716 | <1% | 379 | $8K | |
| 90707 | <1% | 460 | $7K | |
| 87807 | <1% | 561 | $7K | |
| 90633 | <1% | 493 | $6K | |
| 99173 | <1% | 2,128 | $5K | |
| 99072 | <1% | 1,376 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 106 | $5K |
| 90651 | <1% | 135 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 121 | $4K |
| 90734 | <1% | 96 | $3K | |
| 90656 | <1% | 223 | $3K | |
| 0071A | <1% | 53 | $2K | |
| 99177 | <1% | 446 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 758 | $1K |
| 0002A | <1% | 25 | $960.00 | |
| 0072A | <1% | 28 | $920.00 | |
| 90696 | <1% | 44 | $571.85 | |
| 0001A | <1% | 15 | $560.00 | |
| 85018 | <1% | 166 | $384.27 | |
| 90715 | <1% | 28 | $366.48 | |
| 83655 | <1% | 30 | $255.56 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12 | $217.68 |
| 90672 | <1% | 16 | $165.00 | |
| 81002 | <1% | 49 | $138.85 | |
| 91300 | <1% | 137 | $1.01 | |
| 91307 | <1% | 97 | $0.72 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOX, LEE (PRACTICE MANAGER)